Controls are the baseline comparison groups in an experiment. They exist to show what happens when the thing being tested is absent, giving researchers a reference point to measure whether their treatment, drug, or intervention actually made a difference. Without a control, there’s no way to know if the results you’re seeing came from your experiment or from something else entirely.
Why Controls Matter
Imagine you’re testing whether a new fertilizer helps plants grow taller. You apply it to a group of plants, and after six weeks they’ve grown 12 inches. Is that impressive? You have no idea unless you also grew plants without the fertilizer under the same conditions. If those untreated plants grew 11.5 inches, your fertilizer barely did anything. If they grew 4 inches, you’re onto something. That untreated group is your control.
Controls help you understand the influence of variables you can’t fully eliminate from your experiment. Temperature fluctuations, time of day, individual differences between subjects, even the psychological effect of believing a treatment works can all skew results. A well-designed control group absorbs all of those background influences equally, so the only meaningful difference between your groups is the thing you’re actually testing. When the control group is set up correctly, it both validates the experiment and provides the foundation for evaluating whether the treatment had a real effect.
Negative and Positive Controls
There are two fundamental types of controls, and they serve opposite purposes.
A negative control receives no treatment at all. It’s your “nothing should happen” group, and it exists to confirm that your experimental setup isn’t producing false results on its own. Picture a microbiology lab where you’re testing whether a particular surface harbors bacteria. Your negative control would be wiping a sterile, unused swab across a growth plate. No bacteria should appear. If colonies do grow on that plate, something in your setup (your swabs, your plates, your incubator) is contaminated, and your whole experiment is compromised.
A positive control receives a treatment that’s already known to work. It’s your “something definitely should happen” group, and it confirms your experiment is capable of detecting an effect. In that same bacteria experiment, you’d swab an existing bacterial colony onto a plate. Growth should appear. If it doesn’t, something in your setup is killing or suppressing bacteria, which means any negative results in your actual experiment might be meaningless. Positive controls catch problems that negative controls can’t, and vice versa. Most rigorous experiments include both.
Controls in Medical Research
Clinical trials use controls in more nuanced ways because the subjects are people, not petri dishes. The most common approach is a placebo control, where participants receive an inert substance (often a sugar pill) that looks identical to the real treatment. This lets researchers separate the drug’s biological effects from the psychological boost people get simply from believing they’re being treated. The placebo effect is real and measurable, and without a placebo group, it’s impossible to know how much of a drug’s apparent benefit comes from the compound itself.
Placebo controls aren’t always appropriate, though. When a proven treatment already exists for a condition, it can be unethical to give some patients a sugar pill and deny them effective care. In those situations, researchers use an active control: instead of comparing the new drug to nothing, they compare it to the current best treatment. These trials ask a different question. Rather than “does this drug work at all?” they ask “does this drug work at least as well as what we already have?”
There’s also a category called historical controls, where researchers compare current results to data from past studies rather than running a simultaneous control group. The FDA considers this design usable only in unusual circumstances because the inability to control bias is its major limitation. Disease patterns, diagnostic standards, and patient demographics all shift over time, making it difficult to ensure a fair comparison. Historical controls are generally reserved for serious illnesses with no existing treatment and a highly predictable disease course, where withholding a promising therapy feels unjustifiable.
How Randomization and Blinding Protect Controls
A control group only works if it’s truly comparable to the treatment group. If sicker patients end up in one group and healthier patients in the other, the results are meaningless. Randomization solves this by assigning participants to groups by chance, so that age, health status, genetics, and every other variable are distributed roughly equally across both groups. When done properly, any difference in outcomes can be attributed to the treatment rather than to some pre-existing imbalance.
Blinding adds another layer of protection. In a single-blind study, participants don’t know whether they’re receiving the real treatment or the placebo. In a double-blind study, neither the participants nor the researchers interacting with them know. This matters because expectations change behavior. Patients who know they’re getting the real drug may report feeling better. Doctors who know which patients are on the treatment may unconsciously evaluate them more favorably or provide subtly different care. Blinding eliminates these biases by ensuring everyone is treated the same regardless of group assignment.
Together, randomization and blinding are what give control groups their power. Randomization eliminates bias from baseline differences between participants. Blinding eliminates bias from expectations and differential treatment during the study. Without both, even a perfectly conceived control group can produce misleading data.
Controls Are Not Foolproof
Randomized controlled trials are often called the gold standard of medical research, but that label oversimplifies things. A review of the ten most cited randomized trials in the medical literature found multiple unrecognized biases in every single one, including inadequate randomization, initial sample selection bias, incomplete blinding, and even unauthorized use of the study drug in the control group. As pioneering biostatistician Bernard Cornfield put it, “randomization by itself is insufficient. We must indicate the specific variables we wish to control and must devise the specific experimental procedures to control them.”
Sample size also matters enormously. A study with 20 people per group might detect a large, obvious effect but miss a smaller, clinically meaningful one. One statistical analysis found that detecting a modest 7.7% difference between two groups with 80% confidence required roughly 460 participants per group, or 920 total. Underpowered studies with too few participants in the control group can easily miss real effects or produce results that look significant but don’t hold up when repeated.
None of this means controls are unreliable. It means they’re a tool, and like any tool, their value depends on how carefully they’re used. A well-designed control group with proper randomization, adequate blinding, and sufficient sample size remains one of the most powerful methods humans have developed for figuring out what actually works.